Israeli patients aged 70 and older were much less likely to require mechanical ventilation for COVID-19 after most people in their age group had received the second dose of the Pfizer vaccine, according to a study released today by the Centers for Disease Control and Prevention.

Israel initiated a national vaccination campaign using the Pfizer vaccine in December, prioritizing people over 60, health care workers and people with underlying medical conditions. By February, the ratio of COVID-19 patients aged 70 and older requiring mechanical ventilation declined 67% compared with that of patients under 50, the least vaccinated age group.

The authors said the findings provide preliminary evidence of the effectiveness of vaccines in preventing severe cases of COVID-19 in Israel.

Related News Articles

Blog
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…